165 related articles for article (PubMed ID: 33140698)
1. Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates.
Prabitha P; Shanmugarajan D; Kumar TDA; Kumar BRP
J Biomol Struct Dyn; 2022 Apr; 40(6):2663-2673. PubMed ID: 33140698
[TBL] [Abstract][Full Text] [Related]
2. Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists.
Sohn YS; Park C; Lee Y; Kim S; Thangapandian S; Kim Y; Kim HH; Suh JK; Lee KW
J Mol Graph Model; 2013 Nov; 46():1-9. PubMed ID: 24104184
[TBL] [Abstract][Full Text] [Related]
3. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands.
Lewis SN; Garcia Z; Hontecillas R; Bassaganya-Riera J; Bevan DR
J Comput Aided Mol Des; 2015 May; 29(5):421-39. PubMed ID: 25616366
[TBL] [Abstract][Full Text] [Related]
5. Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).
Wang J; Wang B; Zhang Y
J Biomol Struct Dyn; 2020 Feb; 38(2):398-409. PubMed ID: 31025599
[TBL] [Abstract][Full Text] [Related]
6. Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -α/γ dual agonists for treatment of metabolic disorders.
Nath V; Agrawal R; Kumar V
J Biomol Struct Dyn; 2020 Feb; 38(2):511-523. PubMed ID: 30767625
[TBL] [Abstract][Full Text] [Related]
7. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
Singh S; Mohanty A
J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor potentially stable conformations from molecular dynamics as a structure-based pharmacophore model for mapping, screening, and identifying ligands-a new paradigm shift in pharmacophore screening.
Shanmugarajan D; David C
J Biomol Struct Dyn; 2023 Jul; 41(11):4939-4948. PubMed ID: 35543232
[TBL] [Abstract][Full Text] [Related]
9. Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins.
Álvarez-Almazán S; Bello M; Tamay-Cach F; Martínez-Archundia M; Alemán-González-Duhart D; Correa-Basurto J; Mendieta-Wejebe JE
Biochem Pharmacol; 2017 Oct; 142():168-193. PubMed ID: 28716729
[TBL] [Abstract][Full Text] [Related]
10. Exploring Dual Agonists for PPARα/γ Receptors using Pharmacophore Modeling, Docking Analysis and Molecule Dynamics Simulation.
Ding TT; Liu YY; Zhang LM; Shi JR; Xu WR; Li SY; Cheng XC
Comb Chem High Throughput Screen; 2022; 25(9):1450-1461. PubMed ID: 34182904
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel PPARα/γ dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations.
Liu X; Jing Z; Jia WQ; Wang SQ; Ma Y; Xu WR; Liu JW; Cheng XC
J Biomol Struct Dyn; 2018 Aug; 36(11):2988-3002. PubMed ID: 28853334
[TBL] [Abstract][Full Text] [Related]
12. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches.
Jethwa M; Gangopadhyay A; Saha A
J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug design of peroxisome proliferator-activated receptor gamma inhibitors: ferulic acid and derivatives.
Senthil R; Sakthivel M; Usha S
J Biomol Struct Dyn; 2021 Mar; 39(4):1295-1311. PubMed ID: 32151198
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel PPARα/γ Dual Agonists by Virtual Screening of Specs Database.
Zhang J; Liu X; Wang SQ; Fu JW; Xu WR; Cheng XC; Wang RL
Comb Chem High Throughput Screen; 2016; 19(8):644-655. PubMed ID: 27316369
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ.
Ma L; Wang T; Shi M; Ye H
Drug Des Devel Ther; 2016; 10():1807-15. PubMed ID: 27313447
[TBL] [Abstract][Full Text] [Related]
16. Ligand and structure-based computational designing of multi-target molecules directing FFAR-1, FFAR-4 and PPAR-G as modulators of insulin receptor activity.
Mishra S; Rajput MS; Rathore D; Dahima R
J Biomol Struct Dyn; 2022 Sep; 40(15):6974-6988. PubMed ID: 33648410
[TBL] [Abstract][Full Text] [Related]
17. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
18. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
[TBL] [Abstract][Full Text] [Related]
19. Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study.
Okoh OS; Yakubu A; Adegboyega AE; Uti DE; Obeten UN; Agada SA; Oluwaloni F; Johnson GI; Mela LP; Asomadu RO; Iwaloye O; Johnson TO; Orji OU
PLoS One; 2023; 18(5):e0284210. PubMed ID: 37200359
[TBL] [Abstract][Full Text] [Related]
20. Structure-based identification of novel PPAR gamma ligands.
da Silva FM; dos Santos JC; Campos JL; Mafud AC; Polikarpov I; Figueira AC; Nascimento AS
Bioorg Med Chem Lett; 2013 Nov; 23(21):5795-802. PubMed ID: 24075729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
